Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Seco... (ed stimulation parameters. Again these ...)

Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter

Date:11/18/2009

ed stimulation parameters. Again, these efforts will be discussed in greater detail at the investor day presentation.

"With respect to international markets, the Japanese authorities completed a quality audit at our Houston office in the first week of September and a clinical audit in Japan in November."

Mr. Moore concluded, "We are maintaining our longer term goals for our epilepsy business, which include consistent annual unit growth in the range of 10% to 20% and the achievement of an operating margin of 25% by fiscal 2011."

Fiscal 2010 guidance

Based on our first half performance, Cyberonics is increasing its previously provided guidance range for income from operations from $24 million to $27 million to $28 million to $30 million, and increasing its guidance range for net sales from $157 million to $161 million to $159 million to $162 million.

Additional details will be provided during the upcoming conference call and in the accompanying presentation slides, as described below.

Use of Non-GAAP Financial Measures

Management has disclosed financial measurements in this press announcement that present financial information that is not in accordance with Generally Accepted Accounting Principles (GAAP). These measurements are not substitutes for GAAP measurements, although company management uses these measurements as an aid in monitoring the company's on-going financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against other medical technology companies. Non-GAAP net income and non-GAAP diluted earnings per share measure the income of the company excluding the gain on early extinguishment of the company's convertible debt, which is considered by management to be outside of the normal on-going operations of the company. Non-GAAP net income also measures the income of the company excluding the income tax benefit resulting
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine news :

1. Cyberonics Announces Epilepsy Technology Collaborations
2. Cyberonics to Present at Maxim Group Growth Conference
3. Cyberonics to Present at UBS Global Life Sciences Conference
4. Cyberonics Reports Strong Fiscal 2010 First Quarter Results
5. Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference
6. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
7. Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan
8. Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
9. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results
10. Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter
11. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results

Post Your Comments:

(Date:3/21/2010)... March 21 Congressman Chaka Fattah (D-PA) issues the following statement upon passage tonight by the House of Representatives of historic ... ... ... ... ...

(Date:3/21/2010)... , , ... ... Washington : , ... ... The dramatic expansion ...

(Date:3/21/2010)... Statement by Americans United for Life Action President & CEO Dr. Charmaine Yoest : , ... , ... ... ... "Today, Congress ignored the explicit wishes of the American people ...

(Date:3/21/2010)... WASHINGTON , March 22 Speaker Nancy Pelosi spoke on ... the Senate version of health insurance reform legislation by a vote of 219 to 212. ... to improve the Senate bill, passed by a vote of 220 to 211 and goes ... ... ...

(Date:3/21/2010)... American and white cancer patients are treated at similar, ... Published early online in Cancer , a peer-reviewed ... that where patients receive care may partly explain observed ... study, researchers led by Tracy Onega, PhD, MA, of ... than 200,000 Medicare recipients treated for cancer between 1998 ...

[0] Rep. Fattah Says Healthcare Reform Will Work, But Get Ready for Nonsensical Talk About Repeal [0] Concord Coalition Reacts To Health Care Bill Passage: Cost Control Vigilance is Now Crucial [0] Pro-Life Leader Dr. Charmaine Yoest on House Passage of Health Care Legislation [0] Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans'[0] Racial disparities diminish in specialized cancer centers

... evidence that tiny strands of RNA called microRNAs ... cancers, UC Davis researchers have identified one that helps ... disease process, eventually causing it to become fatal. The ... targeting this cellular function and reducing cancer deaths among ...

... Intelligent Device Management,to Streamline Software Delivery to Support ... REDWOOD CITY, Calif., Nov. 28 /PRNewswire-FirstCall/,-- Covidien Ltd. ... leader in advanced,energy-based surgical systems, and Questra Corporation, ... the global launch of,the Valleylab(TM) Exchange Software Update ...

... Neurobiological,Technologies, Inc (NTI (TM)) (Nasdaq: NTII ... Chief Medical Officer, effective as of,November 26, 2007., ... as Vice President, Clinical,Programs with primary responsibility for ... candidate for acute ischemic stroke that is,currently in ...

... Medical Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... that a total of 47 patients,have now undergone ... Aortic Bioprosthesis at seven investigative sites in Europe,within ... Currently,eight patients have surpassed the two year implant ...

... is the Complete Health Resource for Your Dog, Cat, Horse and Other ... ... Nov. 28 Here is the perfect gift for the pet,owner/animal lover on ... Pet Health on its Web site:, http://www.morrisanimalfoundation.org . For a minimum $100 donation, ...

... /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc.,(TSX: NDQ), a developer ... for the operating room, today announced that Dr. ... the corporate story,technology and highlights, including an update ... Focus on Healthcare Conference. The conference,runs from Tuesday, ...

Other Medicine News:Health News:UC Davis researchers identify a cellular pathway that makes prostate cancer fatal 2 Health News:Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System 2 Health News:Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System 3 Health News:ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis 2 Health News:ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis 3 Health News:ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis 4 Health News:Perfect Holiday Gift Idea for the Pet-Animal Lover - Pet Health Manual Available With Donation to Morris Animal Foundation 2 Health News:Novadaq to present at BMO Healthcare Conference 2

UC Davis researchers identify a cellular pathway that makes prostate cancer fatal Covidien Launches First-In-Class, Questra-Based Valleylab(TM) Exchange Software Update System Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis Perfect Holiday Gift Idea for the Pet-Animal Lover - Pet Health Manual Available With Donation to Morris Animal Foundation Novadaq to present at BMO Healthcare Conference

(Date:3/17/2010)... and Company (NYSE: LLY ) today issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 14 ... , ... ... ...

(Date:3/17/2010)... ... ... ... SILVER SPRING, Md. , March 17 The U.S. Food and Drug Administration today announced the approval of the Esteem – an implanted ...

(Date:3/17/2010)... Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . , ... , ... ... ...

[0] Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations [0] FDA Approves First Totally Implanted Hearing System [0] Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum

... EXTON, Pa., Feb. 13 ViroPharma Incorporated (Nasdaq: ... trial evaluating maribavir used as prophylaxis against cytomegalovirus (CMV) ... that all patients on study drug are being moved ... made based on the results of the Phase 3 ...

... and REHOVOT Israel, February 12 ,Rosetta Genomics Ltd. ... ever in-vivo,efficacy data for a systemic microRNA-based cancer ... a microRNA that was,found to be over expressed ... reduction of tumor mass. These data are being ...

Other Medicine Technology:ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients 2 ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients 3 ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients 4 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 2 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 3 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 4 Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer 5

ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....

The Bair Hugger Model 505 provides safe, quiet and effective warming to patients around the world....

The control unit manage patient temperatures during long complex surgical procedures to help achieve optimal clinical outcomes....

The control unit circulates temperature-controlled water through disposable gel pads applied directly to the patient's body....

Medicine Products:

Insulated Suction/Coagulation Probe, single-incision Model 505 -Bair Hugger® Temperature Management Unit Kimberly-Clark Patient Warming System - Model 100 Control Unit Kimberly-Clark Patient Warming System - Model 1000 Control Unit

Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Seco...(ed stimulation parameters. Again these ...),Health